Corpus Intelligence IC Memo — BROOKS REHABILITATION 2026-04-26 15:58 UTC
IC Memo — BROOKS REHABILITATION
Investment Committee Memorandum | FL | 199 beds | Grade B | EBITDA uplift $10.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BROOKS REHABILITATION

CCN 103039 | nan, FL | 199 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

BROOKS REHABILITATION is a 199-bed suburban community hospital in nan, FL with $135.3M in net patient revenue and a -3.9% operating margin. The hospital serves a payer mix of 34.0% Medicare, 2.5% Medicaid, and 63.5% commercial.

Thesis: Undervalued. Our ML models identify $10.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.9% to 3.5% (+736bps).

Net Revenue HCRIS$135.3M
Current EBITDA COMPUTED$-5.2M
Operating Margin COMPUTED-3.9%
Occupancy HCRIS78.1%
Revenue / Bed COMPUTED$680K
Net-to-Gross HCRIS33.9%
Distress Probability ML43.1%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
122
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -3.9% places it below the state median. Among 122 size-comparable peers (100-398 beds), the median margin is 3.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (100-398), prioritizing same-state peers. 122 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BROOKS REHABILITATION (Target)FL199$135.3M-3.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
SOUTH MIAMI HOSPITALFL375$688.4M11.6%
BOCA RATON REGIONAL HOSPITALFL361$609.5M-9.6%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$87K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.6M
Clean Claim Rate
$87K
Total EBITDA Uplift$10.0M
Current EBITDA$-5.2M
+ RCM Uplift+$10.0M
Pro Forma EBITDA$4.7M
Current Margin-3.9%
Pro Forma Margin3.5%
WC Released (1x)$5.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.1M$65.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.1M$68.9M0.00x-100.0%
Bull Case9.0x11.0x$-7.3M$99.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.3M$106.0M0.00x-100.0%
Bear Case11.0x10.0x$-8.9M$17.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.9M$16.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 122 hospitals with 100-398 beds
  • Same-state prioritization (n=123)
  • Comp margins: P25=-6.2% / P50=3.8% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.